We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.99%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
-$3.99B
Cap. Flow
-$1.21B
Cap. Flow %
-2.32%
Top 10 Hldgs %
29.58%
Holding
1,740
New
31
Increased
388
Reduced
563
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Financials 14.62%
3 Healthcare 13.57%
4 Consumer Discretionary 9.97%
5 Communication Services 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USNA icon
1676
Usana Health Sciences
USNA
$429M
$174K ﹤0.01%
6,445
GPRE icon
1677
Green Plains
GPRE
$1.15B
$171K ﹤0.01%
35,214
RLAY icon
1678
Relay Therapeutics
RLAY
$3.99B
$170K ﹤0.01%
64,900
FLNC icon
1679
Fluence Energy
FLNC
$1.68B
$143K ﹤0.01%
29,400
KVYO icon
1680
Klaviyo
KVYO
$5.65B
$141K ﹤0.01%
4,664
-216
-4% -$8.71K
WGS icon
1681
GeneDx Holdings
WGS
$1.84B
$133K ﹤0.01%
1,500
-25,400
-94% -$2.2M
WOLF icon
1682
Wolfspeed
WOLF
$1.14B
$130K ﹤0.01%
42,501
QUBT icon
1683
Quantum Computing Inc
QUBT
$1.74B
$122K ﹤0.01%
+15,250
New +$134K
COGT icon
1684
Cogent Biosciences
COGT
$6.95B
$113K ﹤0.01%
+18,825
New +$148K
ABUS icon
1685
Arbutus Biopharma
ABUS
$871M
$76.3K ﹤0.01%
+21,850
New +$72.9K
G icon
1686
Genpact
G
$5.87B
$70.8K ﹤0.01%
+1,406
New +$69.7K
NIO icon
1687
NIO
NIO
$11.7B
$63K ﹤0.01%
16,526
-845
-5% -$3.72K
OKLO
1688
Oklo
OKLO
$6.89B
$32.4K ﹤0.01%
+1,500
New +$50.7K
ALT icon
1689
Altimmune
ALT
$581M
-454,981
Closed -$3.28M
APGE icon
1690
Apogee Therapeutics
APGE
$10.1B
-69,750
Closed -$3.16M
AURA icon
1691
Aura Biosciences
AURA
$729M
-390,695
Closed -$3.21M
BYND icon
1692
Beyond Meat
BYND
$279M
-40,493
Closed -$152K
CLDT
1693
Chatham Lodging
CLDT
$638M
-47,551
Closed -$426K
CRGX
1694
DELISTED
CARGO Therapeutics
CRGX
-50,000
Closed -$721K
DIN icon
1695
Dine Brands
DIN
$458M
-15,448
Closed -$465K
DNB
1696
DELISTED
Dun & Bradstreet
DNB
-84,545
Closed -$1.05M
ETWO
1697
DELISTED
E2open Parent Holdings
ETWO
-165,400
Closed -$440K
EWTX icon
1698
Edgewise Therapeutics
EWTX
$4.34B
-80,509
Closed -$2.15M
GPCR icon
1699
Structure Therapeutics
GPCR
$3.4B
-308,241
Closed -$8.36M
HAIN icon
1700
Hain Celestial
HAIN
$44.8M
-59,208
Closed -$364K

Similar funds

Ensign Peak Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Ensign Peak Advisors held 1,740 positions worth $52.3B, down 7.1% from $56.3B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.7%. Ensign Peak Advisors opened 31 new positions and exited 51, leaving the 1,740-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2025 buy was iShares Russell 2000 ETF: 355,907 shares worth $71M.
  • Ensign Peak Advisors added most to FTAI Aviation in Q1 2025, an estimated $151M increase.
  • Ensign Peak Advisors's biggest Q1 2025 reduction was Thermo Fisher Scientific, cutting an estimated $156M.
  • Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q1 2025, selling an estimated $302M.
  • Ensign Peak Advisors's ten largest holdings make up 30% of its $52.3B portfolio in Q1 2025.
  • Ensign Peak Advisors opened 31 new positions and closed 51 in Q1 2025.
  • Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.